ketoconazole has been researched along with Neoplasm Metastasis, Unknown Primary in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, CP | 1 |
| Kumar, A | 1 |
| Agarwal, AK | 1 |
| Gupta, H | 1 |
| Gupta, A | 1 |
| Kornely, E | 1 |
| Schlaghecke, R | 1 |
| Horster, FA | 1 |
2 other studies available for ketoconazole and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Cushing's syndrome induced by occult ectopic acth secretion.
Topics: ACTH Syndrome, Ectopic; Adult; Cushing Syndrome; Female; Humans; Hydrocortisone; Ketoconazole; Neopl | 1995 |
Palliative therapy of an ectopic Cushing's syndrome due to a metastatic carcinoid tumor.
Topics: ACTH Syndrome, Ectopic; Adult; Carcinoid Tumor; Combined Modality Therapy; Cushing Syndrome; Dose-Re | 1991 |